News UK approves AZ inhaler with 'greener' propellant AstraZeneca has its first regulatory approval for an inhaler product using a propellant with a massively reduced global warming potential.
News AstraZeneca, Honeywell partner to address climate change wit... UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Gl
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
